Zimmer Biomet
Pharmaceutical & Health Products · Lobbying Client
Zimmer Biomet's Federal Lobbying Record
Zimmer Biomet's $3.6M in disclosed federal lobbying puts it in the mid-tier of registered filers. Spending in the seven-figure range is common for established trade groups, mid-size corporations, and advocacy organizations that maintain a steady but not aggressive presence on Capitol Hill.
Across the 5-year window from 2020 to 2024, Zimmer Biomet's annual disclosed lobbying spend has held roughly steady — $740K at the start versus $769K at the most recent year-end. Year-to-year wobbles inside that range usually reflect timing of legislative cycles rather than a strategic shift.
Zimmer Biomet's disclosed lobbying focuses on a narrow 3-issue footprint. A focused issue list usually means the organization concentrates its federal engagement on a small set of bills or rulemakings directly relevant to its core business.
1 of 2 lobbyists reported by Zimmer Biomet (50%) disclose prior federal government service — a high revolving-door share. The LDA cover sheet flags any "covered position" the lobbyist held in the executive branch, Congress, or a senior staff role within the past two years.
Among the named bench, lobbyists with disclosed prior federal service include Tony C. Podesta (Former Special Counsel, White House Office). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.
Within the Pharmaceutical & Health Products sector, Zimmer Biomet ranks #33 of 34 tracked organizations by disclosed lobbying spend. The sector leader is Pharmaceutical Research & Manufacturers of America at $135.8M; the sector average is $16.7M. Zimmer Biomet's $3.6M sits 78% below the sector average.
Zimmer Biomet's LobbySpend Influence Score of 56/100 (grade C) is the most common grade in the index — it covers organizations with established but moderate federal advocacy programs. The score combines disclosed total spend (40%), issue breadth (30%), and revolving-door connections (30%). A C-grade is typical of mid-size corporations and trade associations with steady quarterly filings on a focused issue set.
Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.
Track Zimmer Biomet's lobbying filings
Subscribe for LobbySpend updates by email. No spam, unsubscribe anytime.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2024 Oct-Dec | Steptoe & Johnson | GOVMED | 1 | $185K |
| 2024 Jul-Sep | Subject Matter | HCRGOV | 2 | $179K |
| 2024 Apr-Jun | Summit Strategies Government Affairs | MEDHCRGOV | 2 | $226K |
| 2024 Jan-Mar | Van Scoyoc Associates | MEDGOV | 2 | $196K |
| 2023 Oct-Dec | Stewart & Stewart | MEDHCR | 2 | $147K |
| 2023 Jul-Sep | Stewart & Stewart | HCRMED | 1 | $176K |
| 2023 Apr-Jun | Cornerstone Government Affairs | MEDHCRGOV | 2 | $164K |
| 2023 Jan-Mar | Hogan Lovells | HCRGOVMED | 2 | $205K |
Zimmer Biomet Lobbying FAQ
Zimmer Biomet has spent $3.6M on federal lobbying across 3 policy areas. This includes spending on registered lobbyists and direct government contacts.
Zimmer Biomet lobbies on 3 policy issues, including Health Issues, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.
Zimmer Biomet has an Influence Score of 56/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).
Zimmer Biomet employs 2 registered lobbyists, of whom 1 have revolving door connections, meaning they previously held government positions before becoming lobbyists.
Zimmer Biomet has contacted 4 government entities as part of their lobbying activities, including National Science Foundation, U.S. Senate, Dept of the Interior.
Explore Other Lobbying Organizations
$387.8M lobbying spend · Trade Association · Influence Score B
$348.2M lobbying spend · Real Estate · Influence Score B
$135.8M lobbying spend · Pharmaceutical & Health Products · Influence Score B
$128.0M lobbying spend · Healthcare · Influence Score B
Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.